메뉴 건너뛰기




Volumn 8, Issue 8, 2016, Pages 1612-1619

Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in mice

Author keywords

antibody antibiotic conjugate; Antibody drug conjugate; pharmacodynamics; pharmacokinetics; Staphylococcus aureus infections; THIOMAB antibody antibiotic conjugate

Indexed keywords

ANTIBODY CONJUGATE; ANTIINFECTIVE AGENT; DMDNA31; DSTA4637A; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; MONOCLONAL ANTIBODY;

EID: 84990946526     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.1080/19420862.2016.1229722     Document Type: Article
Times cited : (64)

References (17)
  • 2
    • 70349226821 scopus 로고    scopus 로고
    • Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
    • 19729844
    • F.R.DeLeo, H.F.Chambers. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest 2009; 119:2464-74; PMID:19729844; http://dx.doi.org/10.1172/JCI38226
    • (2009) J Clin Invest , vol.119 , pp. 2464-2474
    • DeLeo, F.R.1    Chambers, H.F.2
  • 3
    • 84900418033 scopus 로고    scopus 로고
    • Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study
    • 24762631
    • I.Youngster, J.Sauk, C.Pindar, R.G.Wilson, J.L.Kaplan, M.B.Smith, E.J.Alm, D.Gevers, G.H.Russell, E.L.Hohmann. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors:a randomized, open-label, controlled pilot study. Clin Infect Dis 2014; 58:1515-22; PMID:24762631; http://dx.doi.org/10.1093/cid/ciu135
    • (2014) Clin Infect Dis , vol.58 , pp. 1515-1522
    • Youngster, I.1    Sauk, J.2    Pindar, C.3    Wilson, R.G.4    Kaplan, J.L.5    Smith, M.B.6    Alm, E.J.7    Gevers, D.8    Russell, G.H.9    Hohmann, E.L.10
  • 4
    • 79951852718 scopus 로고    scopus 로고
    • Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?
    • 21297670
    • G.E.Thwaites, V.Gant. Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? Nat Rev Microbiol 2011; 9:215-22; PMID:21297670; http://dx.doi.org/10.1038/nrmicro2508
    • (2011) Nat Rev Microbiol , vol.9 , pp. 215-222
    • Thwaites, G.E.1    Gant, V.2
  • 7
    • 84863012529 scopus 로고    scopus 로고
    • Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
    • 22267010
    • B.Q.Shen, K.Xu, L.Liu, H.Raab, S.Bhakta, M.Kenrick, K.L.Parsons-Reponte, J.Tien, S.F.Yu, E.Mai, et al. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates. Nat Biotechnol 2012; 30:184-9; PMID:22267010; http://dx.doi.org/10.1038/nbt.2108
    • (2012) Nat Biotechnol , vol.30 , pp. 184-189
    • Shen, B.Q.1    Xu, K.2    Liu, L.3    Raab, H.4    Bhakta, S.5    Kenrick, M.6    Parsons-Reponte, K.L.7    Tien, J.8    Yu, S.F.9    Mai, E.10
  • 8
    • 84872957381 scopus 로고    scopus 로고
    • Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics
    • 23330562
    • S.Kaur, K.Xu, O.M.Saad, R.C.Dere, M.Carrasco-Triguero. Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics. Bioanalysis 2013; 5:201-26; PMID:23330562; http://dx.doi.org/10.4155/bio.12.299
    • (2013) Bioanalysis , vol.5 , pp. 201-226
    • Kaur, S.1    Xu, K.2    Saad, O.M.3    Dere, R.C.4    Carrasco-Triguero, M.5
  • 9
    • 84877245142 scopus 로고    scopus 로고
    • Bioanalysis of antibody-drug conjugates: American association of pharmaceutical scientists antibody-drug conjugate working group position paper
    • 23641692
    • B.Gorovits, S.C.Alley, S.Bilic, B.Booth, S.Kaur, P.Oldfield, S.Purushothama, C.Rao, S.Shord, P.Siguenza. Bioanalysis of antibody-drug conjugates:American association of pharmaceutical scientists antibody-drug conjugate working group position paper. Bioanalysis 2013; 5:997-1006; PMID:23641692; http://dx.doi.org/10.4155/bio.13.38
    • (2013) Bioanalysis , vol.5 , pp. 997-1006
    • Gorovits, B.1    Alley, S.C.2    Bilic, S.3    Booth, B.4    Kaur, S.5    Oldfield, P.6    Purushothama, S.7    Rao, C.8    Shord, S.9    Siguenza, P.10
  • 10
    • 84856120429 scopus 로고    scopus 로고
    • Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?
    • 22248267
    • R.Deng, F.Jin, S.Prabhu, S.Iyer. Monoclonal antibodies:what are the pharmacokinetic and pharmacodynamic considerations for drug development? Expert Opin Drug Metab Toxicol 2012; 8:141-60; PMID:22248267; http://dx.doi.org/10.1517/17425255.2012.643868
    • (2012) Expert Opin Drug Metab Toxicol , vol.8 , pp. 141-160
    • Deng, R.1    Jin, F.2    Prabhu, S.3    Iyer, S.4
  • 11
    • 78651400009 scopus 로고    scopus 로고
    • Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?
    • 20962582
    • R.Deng, S.Iyer, F.P.Theil, D.L.Mortensen, P.J.Fielder, S.Prabhu. Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data:what have we learned? MAbs 2011; 3:61-6; PMID:20962582; http://dx.doi.org/10.4161/mabs.3.1.13799
    • (2011) MAbs , vol.3 , pp. 61-66
    • Deng, R.1    Iyer, S.2    Theil, F.P.3    Mortensen, D.L.4    Fielder, P.J.5    Prabhu, S.6
  • 14
    • 80052008224 scopus 로고    scopus 로고
    • Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences
    • 21610128
    • W.Wang, P.Lu, Y.Fang, L.Hamuro, T.Pittman, B.Carr, J.Hochman, T.Prueksaritanont. Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences. Drug Metab Dispos 2011; 39:1469-77; PMID:21610128; http://dx.doi.org/10.1124/dmd.111.039453
    • (2011) Drug Metab Dispos , vol.39 , pp. 1469-1477
    • Wang, W.1    Lu, P.2    Fang, Y.3    Hamuro, L.4    Pittman, T.5    Carr, B.6    Hochman, J.7    Prueksaritanont, T.8
  • 16
    • 84992746178 scopus 로고    scopus 로고
    • http://www.lymepa.org/Antibiotics_spreadsheet_2004-1215.pdf
  • 17
    • 64549161964 scopus 로고    scopus 로고
    • Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy
    • 19233622
    • F.C.Tenover, S.W.Sinner, R.E.Segal, V.Huang, S.S.Alexandre, J.E.McGowan, Jr, M.P.Weinstein. Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy. Int J Antimicrob Agents 2009; 33:564-8; PMID:19233622; http://dx.doi.org/10.1016/j.ijantimicag.2008.12.010
    • (2009) Int J Antimicrob Agents , vol.33 , pp. 564-568
    • Tenover, F.C.1    Sinner, S.W.2    Segal, R.E.3    Huang, V.4    Alexandre, S.S.5    McGowan, J.E.6    Weinstein, M.P.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.